Usana Health Sciences (USNA) Liabilities and Shareholders Equity (2011 - 2026)

Usana Health Sciences (USNA) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $739.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 1.02% year-over-year to $739.0 million; the TTM figure through Apr 2026 stood at $2.2 billion (down 21.06% YoY), while the FY2026 annual figure was $742.9 million, down 0.71% from the prior year.
• Liabilities and Shareholders Equity fell to $739.0 million in Q2 2026 per USNA's latest filing, from $742.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $748.2 million in Q4 2024 and bottomed at $556.1 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $643.4 million across 5 years, with a median of $629.3 million in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity dropped 9.85% — and 2025, when it grew 18.64%.
• Usana Health Sciences' Liabilities and Shareholders Equity stood at $596.5 million in 2022, then advanced by 6.07% to $632.8 million in 2023, then grew by 18.24% to $748.2 million in 2024, then dropped by 2.89% to $726.6 million in 2025, then rose by 1.7% to $739.0 million in 2026.
• Business Quant data shows USNA's Liabilities and Shareholders Equity at $739.0 million in Q2 2026, $742.9 million in Q1 2026, and $726.6 million in Q3 2025.